Neurodegeneration

lab

Establishing sNfL as an MS Biomarker

3300 2200 Carlotta Foletti, PhD

At the ECTRIMS annual congress in October 2018, there was a lot of talk on serum neurofilament light (sNfL) becoming the first blood biomarker predicting neuronal damage caused by neurological…

read more
news

News from the ocrelizumab front

3300 2200 Carlotta Foletti, PhD

In our ongoing coverage of the AAN Annual Meeting in Philadelphia, we are focusing on select posters reporting on studies of ocrelizumab, an intravenous humanised monoclonal antibody that selectively targets…

read more

Will new understanding equal new treatments for toxic ALS mutation?

3139 2200 Peter Stevenson, PhD

Researchers may have solved the mystery surrounding the most common genetic cause of amyotrophic lateral sclerosis (ALS), marking out new territory in which to explore possible treatments. ALS, also known…

read more

Young neurons in mature brains

3150 2100 Peter Stevenson, PhD

A new study uncovered the existence of immature neurons in adult brains well into old age, adding more weight to the longstanding debate of whether neurogenesis really stops after adolescence.…

read more

Could the gut-brain axis have a role in stroke recovery?

3300 2200 Peter Stevenson, PhD

Acute disruption of bacterial populations in the gut after stroke could have a detrimental effect on recovery, according to new research. The role that our microbiome – the microbial environment…

read more

Genetic link uncovered that could help protect against PTSD

3150 2100 Peter Stevenson, PhD

A new study has identified a link between fear memory and TIA1, a prion-related RNA-binding protein whose capacity to form various types of intracellular aggregates has been implicated in neurodegenerative…

read more

FDA issues warnings on illegal Alzheimer’s drugs

2880 1920 Peter Stevenson, PhD

On 11 February 2019, the United States Food and Drug Administration (FDA) issued warnings to 17 companies that illegally sold more than 50 products claiming to prevent, treat or cure…

read more

‘Leaky’ blood vessels linked to Alzheimer’s

3500 2333 Peter Stevenson, PhD

Leaky blood vessels in the brain appear to be a driver of cognitive dysfunction in Alzheimer’s disease, a new study reports. The research, published in Nature Medicine, followed 161 older…

read more

Herpes and Alzheimer’s: Trigger or symptom?

1920 1280 Peter Stevenson, PhD

A new review article, published in Frontiers in Aging Neuroscience, has offered fresh evidence in support of a link between the Herpes Simplex Virus 1 (HSV1) and Alzheimer’s disease (AD).…

read more

Cognitive impairment in MS

2048 1153 Mea Holm, PhD

Up to 70% of MS patients suffer from cognitive decline, which often has a profound impact on an individual’s quality of life. It is little surprise that MS researchers are…

read more
Brainwork is supported by unrestricted grants from: